Sales & Marketing | Connecting with physicians and patients

News

NHS to offer Wegovy to a million more people in England

The NHS in England will make Novo Nordisk's Wegovy available to around 1.2m people in order to reduce their risk of heart attacks and strokes.

News

Novo hits back at rivals with cut-price Wegovy subscriptions

Trying to claw back market share in the weight-loss category, Novo Nordisk has launched a subscription-based service for Wegovy cash payers.

News

Biogen swoops on Apellis with $5.6bn offer

In today's second sizeable M&A deal, Biogen has agreed to buy Apellis for around $5.6 billion, building on its aspirations in nephrology.

News

UCB brings first therapy for rare disease TK2d to EU

The EU has approved UCB's Kygevvi for rare disease TK2d, and Sanofi's acute GvHD therapy Rezurock, in a pair of decisions announced this morning.

Sales & Marketing

Commercial teams are running yesterday's plays. AI just chan...

What leading companies are building now is fundamentally different: decision systems.

News

Appeal finds NICE must reconsider Alzheimer's drugs

Lilly and Eisai's bid to secure NHS coverage of their Alzheimer's therapies has entered a new phase, after an appeal of last year's rejection by NICE.

News

Generic semaglutide in India, and other weight-loss news

Novo Nordisk is facing generic semaglutide in India, Atrogi is testing a new weight loss approach, and Structure has more data with its oral GLP-1.

News

Alfasigma claims early FDA nod for ex-GSK liver drug

Alfasigma has claimed the first approval, in the US, for linerixibat, a drug for liver disease PBC licensed from GSK for $690m a few days ago.

News

NHS to offer Wegovy to a million more people in England

The NHS in England will make Novo Nordisk's Wegovy available to around 1.2m people in order to reduce their risk of heart attacks and strokes.

News

Novo hits back at rivals with cut-price Wegovy subscriptions

Trying to claw back market share in the weight-loss category, Novo Nordisk has launched a subscription-based service for Wegovy cash payers.

Press Releases

News

Sanofi grabs Chinese rights to Arrowhead rare disease drug

Sanofi has paid $130 million upfront for Chinese rights to an Arrowhead Pharma drug for rare disease familial chylomicronaemia syndrome.

Sales & Marketing

Partner Content

Pharma Equipment Auction: Surepharm Assets Sale

Bid on used pharmaceutical production and packaging equipment. View auction April 22-24.

Views & Analysis

Sales & Marketing

Commercial teams are running yesterday's plays. AI just chan...

What leading companies are building now is fundamentally different: decision systems.

Sales & Marketing

Sponsored

What HCPs Say Pharma Gets Wrong About Survey Research

Most market researchers already know the standard rules: keep surveys concise, write clear questions, and reduce unnecessary respondent burden.

Deep Dive

Sales & Marketing

Deep Dive: Commercialisation 2024

In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.

Sales & Marketing

Five top tips for developing a communication strategy

Sales & Marketing

Assessing the global applicability of the UK’s ‘Netflix’-sty...

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Sponsored

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Sales & Marketing

Physicians walking and using tablet devices

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Sales & Marketing

Sponsored

Health Trends 2025: Reimagining What's Possible

Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl

Podcasts

Sales & Marketing

Sponsored

From Buzzword to Strategy: Reverba Global Talks Omnichannel ...

Sales & Marketing

pharmaphorum podcast Episode 243, Lisa Sims, Novartis

On quality data for quality learnings, with Lisa Sims

Nicole Raleigh speaks with Lisa Sims, executive director of learning strategy & operations at Novartis, about personalising learning at scale.

Sales & Marketing

pharmaphorum podcast Episode 212, Bayer and Veeva

Collaborating on a connected platform journey, with Alexande...

pharmaphorum speaks with Bayer's Alexander Alex and Veeva's Florian Schnappauf about Bayer's recent migration to the connected Vault CRM platform.

Video

Sales & Marketing

Interview at JPM26 with Helen Sabzevari and Greg Skalicky

Rewiring commercialisation to meet the moment, with Helen Sa...

At the Informa Biotech Showcase at JPM2026, EVERSANA President Greg Skalicky and Helen Sabzevari, CEO of Precigen, discuss new commercialisation.

Sales & Marketing

Sponsored

Bridging science and strategy: Medical Affairs at the heart ...

In this sponsored podcast, Cheryl Lubbert and Carolyn Whiting of Reverba discuss a new approach to pharma marketing, omnichannel, and medical affairs.

Sales & Marketing

The Future of Pharma Marketing featuring Dan Gandor, Brooke Fleming, Stacy Stone, Tarak Shah and Paul Murasko

The future of pharma marketing – A pharmaphorum executive ro...

White Papers

Sales & Marketing

Sponsored

What HCPs Say Pharma Gets Wrong About Survey Research

Most market researchers already know the standard rules: keep surveys concise, write clear questions, and reduce unnecessary respondent burden.

Sales & Marketing

Lumanity white paper - person at top of mountain range

Sponsored

The strategic imperative of Integrated Evidence Generation P...

Integrated Evidence Generation Planning (IEGP) is recognised as a strategic necessity for biopharmaceutical organisations.

Sales & Marketing

Sponsored

5 strategies to retain top talent

The pharma sales industry is in the midst of rapid transformation, fuelled by digital disruption and dynamic market forces.

Event

Sales & Marketing

Partner Content

The ESG in Life Sciences Summit is coming to the West Coast!

The ESG in Life Sciences Summit West is coming to San Francisco! (July 8-10, 2025).

Sales & Marketing

Reuters Pharma Barcelona 2023 - Day 2

Moving into Day Two – if you missed it, do be sure to catch up on yesterday’s coverage here – pharmaphoru

Debates & Insight

Sponsored

How to optimise pharma’s digital HCP engagement

Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if they are to bridge the gap between the value a compan

Sales & Marketing

Sponsored

An integrated CRM saves time, money and drives sales efficie...

Like most pharmaceutical companies, Théa Pharma places the utmost importance on quality customer data – but non-integrated systems were holding the team back.

Debates & Insight